FNBT
TMO icon

FineMark National Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History

FineMark National Bank & Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.7M Sell
21,990
-815
-4% -$461K 0.4% 66
2025
Q3 		$11.1M Sell
22,805
-44
-0.2% -$20.5K 0.36% 74
2025
Q2 		$9.26M Sell
22,849
-292
-1% -$122K 0.32% 79
2025
Q1 		$11.5M Buy
23,141
+456
+2% +$247K 0.42% 72
2024
Q4 		$11.8M Buy
22,685
+187
+0.8% +$103K 0.41% 71
2024
Q3 		$13.9M Sell
22,498
-228
-1% -$135K 0.48% 63
2024
Q2 		$12.6M Buy
22,726
+468
+2% +$268K 0.46% 65
2024
Q1 		$12.9M Buy
22,258
+189
+0.9% +$106K 0.48% 63
2023
Q4 		$11.7M Buy
22,069
+447
+2% +$216K 0.48% 60
2023
Q3 		$10.9M Buy
21,622
+16,160
+296% +$8.61M 0.48% 58
2023
Q2 		$2.85M Sell
5,462
-47
-0.9% -$25.4K 0.12% 134
2023
Q1 		$3.18M Buy
5,509
+605
+12% +$341K 0.14% 124
2022
Q4 		$2.7M Sell
4,904
-68
-1% -$36K 0.12% 132
2022
Q3 		$2.52M Buy
4,972
+161
+3% +$90.1K 0.12% 133
2022
Q2 		$2.61M Buy
4,811
+22
+0.5% +$12.1K 0.12% 135
2022
Q1 		$2.83M Buy
4,789
+87
+2% +$50K 0.11% 137
2021
Q4 		$3.14M Buy
4,702
+452
+11% +$282K 0.12% 132
2021
Q3 		$2.43M Buy
4,250
+8
+0.2% +$4.39K 0.1% 135
2021
Q2 		$2.14M Buy
4,242
+46
+1% +$21.7K 0.09% 141
2021
Q1 		$1.92M Sell
4,196
-19
-0.5% -$9.07K 0.08% 149
2020
Q4 		$1.96M Buy
4,215
+55
+1% +$25.8K 0.09% 140
2020
Q3 		$1.84M Hold
4,160
– – 0.09% 134
2020
Q2 		$1.51M Sell
4,160
-26
-0.6% -$8.71K 0.08% 133
2020
Q1 		$1.19M Sell
4,186
-38
-0.9% -$12K 0.07% 141
2019
Q4 		$1.37M Buy
4,224
+392
+10% +$119K 0.07% 152
2019
Q3 		$1.12M Hold
3,832
– – 0.06% 164
2019
Q2 		$1.13M Buy
3,832
+989
+35% +$272K 0.06% 158
2019
Q1 		$778K Sell
2,843
-72
-2% -$17.9K 0.05% 192
2018
Q4 		$652K Buy
2,915
+337
+13% +$79.1K 0.04% 208
2018
Q3 		$629K Sell
2,578
-146
-5% -$33.6K 0.04% 200
2018
Q2 		$564K Sell
2,724
-7
-0.3% -$1.49K 0.03% 239
2018
Q1 		$564K Buy
2,731
+200
+8% +$42K 0.04% 234
2017
Q4 		$481K Sell
2,531
-160
-6% -$30.7K 0.03% 235
2017
Q3 		$509K Sell
2,691
-25
-0.9% -$4.53K 0.03% 231
2017
Q2 		$474K Sell
2,716
-23
-0.8% -$3.86K 0.03% 230
2017
Q1 		$421K Sell
2,739
-12,638
-82% -$1.93M 0.03% 242
2016
Q4 		$2.17M Sell
15,377
-1,294
-8% -$191K 0.17% 106
2016
Q3 		$2.17M Buy
16,671
+4,189
+34% +$646K 0.23% 104
2016
Q2 		$1.84M Buy
12,482
+10,568
+552% +$1.56M 0.21% 105
2016
Q1 		$271K Buy
1,914
+160
+9% +$21.4K 0.03% 270
2015
Q4 		$249K Sell
1,754
-66
-4% -$8.8K 0.03% 290
2015
Q3 		$223K Buy
1,820
+96
+6% +$12.5K 0.03% 314
2015
Q2 		$224K Hold
1,724
– – 0.03% 320
2015
Q1 		$232K Buy
1,724
+100
+6% +$12.9K 0.03% 324
2014
Q4 		$203K Hold
1,624
– – 0.03% 343
2014
Q3 		$198K Hold
1,624
– – 0.03% 339
2014
Q2 		$192K Hold
1,624
– – 0.03% 333
2014
Q1 		$195K Sell
1,624
-583
-26% -$69.3K 0.04% 321
2013
Q4 		$245K Sell
2,207
-8
-0.4% -$795 0.05% 283
2013
Q3 		$205K Hold
2,215
– – 0.05% 294
2013
Q2 		$188K Buy
+2,215
New +$184K 0.06% 285

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FineMark National Bank & Trust's TMO Position: Q4 2025 in Review

FineMark National Bank & Trust reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q4 2025, selling an estimated $461K and leaving 21,990 shares worth $12.7M. The position accounts for 0.4% of the portfolio, ranked #66.

FineMark National Bank & Trust first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.9M in Q3 2024. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • FineMark National Bank & Trust held 21,990 shares of Thermo Fisher Scientific worth $12.7M as of Q4 2025.
  • FineMark National Bank & Trust sold 815 Thermo Fisher Scientific shares in Q4 2025, an estimated $461K.
  • Thermo Fisher Scientific made up 0.4% of FineMark National Bank & Trust's portfolio in Q4 2025, its #66 holding.
  • FineMark National Bank & Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
  • FineMark National Bank & Trust's Thermo Fisher Scientific position peaked at $13.9M in Q3 2024.
  • 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.